CBI’s Compounding Pharmacy Compliance is the only event that specifically addresses compliance challenges facing both 503A and 503B compounding pharmacies.
Veranstaltungsart: Seminar
- Standort:
- Washington D.C.
- Startdatum / -uhrzeit:
- 17 May 2018
- Enddatum / -uhrzeit:
- 18 May 2018
Through a mix of general sessions and dual 503A and 503B tracks our expert faculty will lead discussions and interactive learning sessions to best help pharmacy organizations come under compliance and address FDA and State Pharmacy Board audits.